UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-32830 INDIA GLOBALIZATION CAPITAL, INC. (Exact name of registrant as specified in its charter) Maryland 20-2760393 (I.R.S. Employer Identification No.) (State or other jur ...

Revenue Performance - Revenue for the three months ended June 30, 2020, was approximately $584 thousand, a decrease of 65% from $1,649 thousand in the same period in 2019[124] - The Life Sciences segment generated $584 thousand in revenue for the quarter ended June 30, 2020, compared to $104 thousand in the same quarter of 2019, reflecting a significant shift in product mix[125] Cost and Expenses - Cost of revenue decreased to approximately $538 thousand in Q2 2020 from $1,608 thousand in Q2 2019, a reduction of 67%[126] - Selling, general and administrative expenses increased by approximately $506 thousand or 41% to $1,755 thousand for the three months ended June 30, 2020, primarily due to one-time legal expenses[127] - Research and development expenses for the three months ended June 30, 2020, were approximately $222 thousand, down from $247 thousand in the same period in 2019[128] Cash Flow and Liquidity - Net cash used in operating activities was approximately $4 million for the three months ended June 30, 2020, compared to $2.9 million in the same period in 2019, representing a 39% increase[139] - Cash and cash equivalents decreased by approximately $4,555 thousand to $2,703 thousand as of June 30, 2020, a decline of 63% from $7,258 thousand as of March 31, 2020[136] COVID-19 Impact - The company expects volatility in both the Life Sciences and Infrastructure segments due to the ongoing impact of COVID-19, with limited visibility on revenue stabilization[125] - The company is actively monitoring the impact of COVID-19 on its financial condition, liquidity, and operations[133] - The company anticipates a decrease in general and administrative expenses as one-time legal and other expenses are expected to abate over the rest of the year[127]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Commission file number: 001-32830 INDIA GLOBALIZATION CAPITAL, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland (State or other jurisdiction of incorporation or organization) 10224 Falls Road, Potomac, Maryland (Address of Principal Executive Offices) (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Common Stock IGC NYSE American LLC (Name of e ...

☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended December 31, 2019 ☐ Transition report under Section 13 or 15(d) of the Exchange Act of 1934 Commission file number: 001-32830 INDIA GLOBALIZATION CAPITAL, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of incorporation or organization) 20-2760393 (I.R.S. Emp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2019 Maryland (State or other jurisdiction of incorporation or organization) 20-2760393 (I.R.S. Employer Identification No.) 10224 Falls Road, Potomac, Maryland ☐ Transition report under Section 13 or 15(d) of the Exchange Act of 1934 (Address of principal executive offices) Commission file num ...

Revenue and Income - Revenue for the three months ended June 30, 2019, was approximately $1.65 million, an increase of $171 thousand or 12% compared to $1.48 million in the same period in 2018[95]. - Other income rose by approximately $77 thousand or 7700%, totaling $76 thousand for the three months ended June 30, 2019, compared to a loss of $1 thousand in 2018[100]. Costs and Expenses - Cost of revenue for the same period was approximately $1.6 million, reflecting an increase of $172 thousand or 12% from $1.4 million in 2018, primarily due to increased purchases of physical commodities[97]. - General and administrative expenses surged by approximately $732 thousand or 142% to $1.2 million for the three months ended June 30, 2019, largely due to legal and professional fees related to shareholder lawsuits[98]. - Research and development expenses increased significantly by approximately $211 thousand or 586% to $247 thousand, primarily for the Plant and Cannabinoid Business[99]. Cash Flow - Cash and cash equivalents decreased by approximately $9 million to $16.55 million as of June 30, 2019, a decline of 35% from $25.61 million on March 31, 2019[103]. - Net cash used in operating activities was $2.87 million for the three months ended June 30, 2019, compared to $535 thousand in the same period in 2018, representing an increase of 437%[106]. - Net cash used in investing activities was $6.19 million, significantly up from $8 thousand in the same period in 2018, primarily due to investments in mutual funds and office space[108]. Business Strategy and Market Outlook - The company is exploring acquisitions, investments, or joint ventures to enhance its Plant and Cannabinoid Business as market demand for hemp products is expected to grow[94]. - The company’s product mix is anticipated to include hemp/CBD-infused drinks, tinctures, and oils, among others, as part of its strategy to expand its market presence[94].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Commission file number: 001-32830 INDIA GLOBALIZATION CAPITAL, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland (State or other jurisdiction of incorporation or organization) (Title of each class) Common Stock IGC NYSE American LLC (Name of each exchange on which registered) (Trading Symbol) Securities registered pursuant to Section 12(g) of the Act: Common Stock Purchase Warrants 12224 Falls Road, Potomac, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission file number: 001-32830 INDIA GLOBALIZATION CAPITAL, INC. (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of incorporation or organization) If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of th ...